HIV seroprevalence in three population groups

Many strategies exist for HIV antibody testing. Using a combination of an Enzyme immunoassay and Western Blotting; we found anti-HIV seroprevalence of 1.6 per cent; 1.2 per cent and 34.8 per cent in blood donors; pregnant women and patients with clinical symptoms of AIDS; respectively. Due to worldwide interest in the epidemiology of HIV disease; correct identification of infected people is important. The false labelling of people as seropositive only on ELISA screening has psychological implications. The importance of anti-HIV confirmatory testing when the test objective is diagnosis is stressed